ViaDerma, Inc. Commences Distribution of VitaStem(TM), its FDA Registered Topical Antibiotic, and Looks to Expand its Partnership with Biogenx
October 19, 2017 at 01:57 pm EDT
Share
ViaDerma, Inc. announced that the Company has begun distribution of its highly anticipated topical antibiotic ointment. Its marketing, sales and distribution partner, Biogenx, Inc. has been preselling the product, under the name of VitaStem™, which retails for $99 and can be purchased online at www.Biogenx.net. The Company's manufacturing partner has completed the first production run of 15,000 units of the product overcoming several manufacturing delays. The Company expects to ramp up production on a monthly basis and the first orders shipped out yesterday. Since the promising results of clinical studies of VitaStem in hospital groups in Japan and the Philippines, the Company will send a portion of the first run to Japan and the Philippines. The Distributors are also interested in ViaDerma's several follow-on products, using ViaDerma's proprietary solution, which the Company is expecting additional FDA registration numbers throughout the rest of 2017.
ViaDerma, Inc. is a specialty pharmaceutical company engaged in bringing new products to market and licensing its transdermal drug delivery technology solutions. The Companyâs lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. In addition to licensing its proprietary transdermal technologies, its lead product, Vitastem, is available for treating multiple skin conditions and ailments. The Company also has products in development in fields, such as anti-aging skin care, pain management, hair-loss, and toenail fungus. The products are based on a delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Companyâs products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Companyâs subsidiary is ViaDerma, II Inc.